Cargando…
Progress in the mechanism and targeted drug therapy for COPD
Chronic obstructive pulmonary disease (COPD) is emphysema and/or chronic bronchitis characterised by long-term breathing problems and poor airflow. The prevalence of COPD has increased over the last decade and the drugs most commonly used to treat it, such as glucocorticoids and bronchodilators, hav...
Autores principales: | Wang, Cuixue, Zhou, Jiedong, Wang, Jinquan, Li, Shujing, Fukunaga, Atsushi, Yodoi, Junji, Tian, Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588592/ https://www.ncbi.nlm.nih.gov/pubmed/33110061 http://dx.doi.org/10.1038/s41392-020-00345-x |
Ejemplares similares
-
Thioredoxin-1: A Promising Target for the Treatment of Allergic Diseases
por: Wang, Jinquan, et al.
Publicado: (2022) -
Redox Regulation in Aging Lungs and Therapeutic Implications of Antioxidants in COPD
por: Kiyokawa, Hirofumi, et al.
Publicado: (2021) -
Thioredoxin Ameliorates Cutaneous Inflammation by Regulating the Epithelial Production and Release of Pro-Inflammatory Cytokines
por: Tian, Hai, et al.
Publicado: (2013) -
Pathological Mechanism and Targeted Drugs of COPD
por: Guo, Peng, et al.
Publicado: (2022) -
Anti-Inflammatory Thioredoxin Family Proteins for Medicare, Healthcare and Aging Care
por: Yodoi, Junji, et al.
Publicado: (2017)